High Throughput Chemistry & Chemical Biology

The 2013 GRC on High-Throughput Chemistry and Chemical Biology (HTCCB) will feature cutting edge talks bridging the disciplines of organic chemistry and chemical biology, covering a diverse range of topics. Invited speakers from both industry and academia will focus on the latest advances in synthetic methodology, reaction discovery, chemical biology, medicinal chemistry, library synthesis and screening. An overarching theme of the meeting is the application of high-throughput experimentation to research problems in these fields.

The HTCCB GRC will continue its tradition of excellent science in a relaxed atmosphere and will be held at Colby-Sawyer College in New London, NH. All conferees are encouraged to present a poster, as the afternoon poster sessions are an important part of the scientific and social exchange at the HTCCB GRC. The GRC has historically provided a unique gathering where colleagues and friends engage in informal discussion and exchange of ideas, and the 2013 meeting is set to provide likewise.

I am especially pleased to announce that the 3rd Gordon Research Seminar (GRS) for our conference will be held the weekend prior to the GRC on June 1-2. The HTCCB GRS is being organized by Jacqueline Wurst (The Broad Institute) and Joanna Loh (University of Kansas) and will provide an opportunity for trainees to share science and interact with leading researchers in an intimate setting. Graduate students and post-docs are encouraged to apply to both the GRS and GRC.

Along with the conference Vice-Chair, Scott Wolkenberg (Merck), I invite you to apply to what I hope to be an exciting and memorable meeting.

Lisa Marcaurelle
Chair 2013
GRC on High-Throughput Chemistry and Chemical Biology
H3 Biomedicine, Inc.
+ show speakers and program
Preliminary List of Speakers

Emily Balskus, Harvard University
Carolyn Bertozzi, University of California Berkeley
Dale Boger, The Scripps Research Institute
Albert Bowers, Purdue University
Matthew Boxer, NIH/NCATS
James Bradner, Dana Farber Cancer Institute
Ivan Cornella-Taracido, Sanofi
Richard Cummings, Constellation Pharmaceuticals
Abigail Doyle, Princeton University
Spencer Dreher, Merck
Martin Drysdale, The Beatson Institute for Cancer Research
Jeremy Duvall, Broad Institute
M.G. Finn, Georgia Institute of Technology
Sam Gerritz, Bristol-Myers Squibb
Stefan Gradl, Chiromics
John Hartwig, University of California Berkeley
Yujiro Hayashi, Tohoku University
Christopher Helal, Pfizer
Jiyong Hong, Duke University
Andrew Hopkins, University of Dundee
Tim Jamison, Massachusetts Institute of Technology
Jeremy Jenkins, Novartis
Lyn Jones, Pfizer
Rene Lemieux, Agios
David Maloney, NIH/NCATS
Adam Nelson, University of Leeds
Robert Nicewonger, Eisai
Thomas Nielsen, Technical University of Denmark
Andy Phillips, Yale University
Jennifer Prescher, University of California Irvine
Sarah Reisman, California Institute of Technology
Stuart Schreiber, Harvard University
Jared Shaw, University of California Davis
Derek Tan, Memorial Sloan-Kettering Cancer Center
Herbert Waldmann, Max Planck Institute
Markus Warmuth, H3 Biomedicine
Andrei Yudin, University of Toronto

A list of preliminary session topics and speakers is currently being developed by the Conference Chair and will be available by December 1, 2012. Please check back for updates.

2 Jun - 7 Jun 2013
New London
United States of America
meeting website